Cargando…

A Retrospective Analysis of the Correlation between Functional Imaging and Clinical Outcomes in Grade 3 Neuroendocrine Tumors (NETs G3)

Grade 3 (G3) neuroendocrine tumors (NETs) are a novel category among digestive neuroendocrine neoplasms, characterized by Ki-67 >20% and a well-differentiated morphology, presenting high intra-tumor heterogeneity. We aimed to explore the role of dual-tracer PET imaging ((68)Gallium (Ga)-DOTATOC a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laffi, Alice, Colandrea, Marzia, Buonsanti, Giuseppe, Frassoni, Samuele, Bagnardi, Vincenzo, Spada, Francesca, Pisa, Eleonora, Barberis, Massimo, Rubino, Manila, Grana, Chiara Maria, Ceci, Francesco, Fazio, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700454/ https://www.ncbi.nlm.nih.gov/pubmed/34943637 http://dx.doi.org/10.3390/diagnostics11122401

Ejemplares similares

Metronomic chemotherapy in patients with advanced neuroendocrine tumors: A single‐center retrospective analysis
por: Arrivi, Giulia, et al.
Publicado: (2022)

Gastric Neuroendocrine Tumors (g-NETs): A Systematic Review of the Management and Outcomes of Type 3 g-NETs
por: Laffi, Alice, et al.
Publicado: (2023)

Addressing the Role of Angiogenesis in Patients with Advanced Pancreatic Neuroendocrine Tumors Treated with Everolimus: A Biological Prospective Analysis of Soluble Biomarkers and Clinical Outcomes
por: Cella, Chiara Alessandra, et al.
Publicado: (2022)

Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management
por: Spada, Francesca, et al.
Publicado: (2021)

Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study
por: Fazio, Nicola, et al.
Publicado: (2021)

[(18)F]FDG PET/CT: Lung Nodule Evaluation in Patients Affected by Renal Cell Carcinoma
por: Airò Farulla, Lighea Simona, et al.
Publicado: (2023)

Validation of the ONKOTEV Risk Prediction Model for Venous Thromboembolism in Outpatients With Cancer
por: Cella, Chiara A., et al.
Publicado: (2023)

Corrigendum to ‘Coronavirus disease 2019 in patients with neuroendocrine neoplasms: Preliminary results of the INTENSIVE study’ [European Journal of Cancer 154 (2021) 246-252]
por: Fazio, Nicola, et al.
Publicado: (2022)

Nodal Merkel Cell Carcinoma with Unknown Primary Site and No Distant Metastasis: A Single-Center Series
por: Fazio, Nicola, et al.
Publicado: (2022)

SARS-CoV-2-related pneumonia can be successfully managed in patients with metastatic neuroendocrine tumors: a critical point of view
por: Spada, F., et al.
Publicado: (2020)

Observational Study on Antibody Response to COVID-19 Vaccines in PAtients with Gastro-Entero-PanCreatic Cancers and NeuroendocrIne NeoplAsms on Systemic TreatmEnts (VACCINATE)
por: Laffi, Alice, et al.
Publicado: (2023)

The rare entity of bilateral and unilateral neuroendocrine metastases to the breast: a case series and literature review
por: Zagami, Paola, et al.
Publicado: (2020)

Gastroenteropancreatic Neuroendocrine Carcinomas: The NET G3 Subcategory Is a Reality
por: Fazio, Nicola, et al.
Publicado: (2017)

Grade 3 Neuroendocrine Tumor (G3NET): An Unusual Tumor With A Histochemical Surprise
por: Singhal, Sachi, et al.
Publicado: (2021)

The European Institute of Oncology Thyroid Imaging Reporting and Data System for Classification of Thyroid Nodules: A Prospective Study
por: De Fiori, Elvio, et al.
Publicado: (2022)

Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3)
por: Apostolidis, Leonidas, et al.
Publicado: (2021)

Targeted Genomic Profiling and Chemotherapy Outcomes in Grade 3 Gastro-Entero-Pancreatic Neuroendocrine Tumors (G3 GEP-NET)
por: Lamberti, Giuseppe, et al.
Publicado: (2023)

A Model to Predict Upstaging to Invasive Carcinoma in Patients Preoperatively Diagnosed with Low-Grade Ductal Carcinoma In Situ of the Breast
por: Nicosia, Luca, et al.
Publicado: (2022)

A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy
por: Hasic Telalovic, Jasminka, et al.
Publicado: (2021)

Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches
por: Lania, Andrea, et al.
Publicado: (2021)

Radiomics in pulmonary neuroendocrine tumours (NETs)
por: Cozzi, Diletta, et al.
Publicado: (2022)

(18)F-FDG PET/CT in asymptomatic patients with COVID-19: the submerged iceberg surfaces
por: Colandrea, Marzia, et al.
Publicado: (2020)

Surgical Resection vs. Percutaneous Ablation for Single Hepatocellular Carcinoma: Exploring the Impact of Li-RADS Classification on Oncological Outcomes
por: Centonze, Leonardo, et al.
Publicado: (2021)

Metachronous Testicular Metastases from Merkel Cell Carcinoma (MCC): A Case Report and Literature Review
por: Laffi, Alice, et al.
Publicado: (2022)

Hands-On RESTful Web Services with ASP.NET Core 3
por: Resca, Samuele
Publicado: (2019)

Reply to comments on ‘COVID-19 in patients with neuroendocrine neoplasms: Preliminary results of a worldwide survey (The INTENSIVE study)’
por: Fazio, Nicola, et al.
Publicado: (2021)

Lymphopenia in patients affected by SARS-CoV-2 infection is caused by margination of lymphocytes in large bowel: an [(18)F]FDG PET/CT study
por: Signore, Alberto, et al.
Publicado: (2022)

Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020)

Exploration of Novel Prognostic Markers in Grade 3 Neuroendocrine Neoplasia
por: Abdelmalak, Rebecca, et al.
Publicado: (2021)

Intraoperative Extra Corporeal Membrane Oxygenator for Lung Cancer Resections Does Not Impact Circulating Tumor Cells
por: Petrella, Francesco, et al.
Publicado: (2022)

Clinicopathological Features of Primary Neuroendocrine Tumors of Gastrointestinal/Pancreatobiliary Tract With Emphasis on High-Grade (Grade 3) Well-Differentiated Neuroendocrine Tumors
por: Hashmi, Atif A, et al.
Publicado: (2021)

A Score to Predict the Malignancy of a Breast Lesion Based on Different Contrast Enhancement Patterns in Contrast-Enhanced Spectral Mammography
por: Nicosia, Luca, et al.
Publicado: (2022)

PD-L1 expression in gastroenteropancreatic neuroendocrine neoplasms grade 3
por: Ali, Abir Salwa, et al.
Publicado: (2020)

Two Pituitary Neuroendocrine Tumors (PitNETs) with Very High Proliferation and TP53 Mutation — High-Grade PitNET or PitNEC?
por: Saeger, Wolfgang, et al.
Publicado: (2021)

Pregnant with metastatic neuroendocrine tumour of the ovary: what now?
por: Pistilli, B, et al.
Publicado: (2012)

First Live-Experience Session with PET/CT Specimen Imager: A Pilot Analysis in Prostate Cancer and Neuroendocrine Tumor
por: Muraglia, Lorenzo, et al.
Publicado: (2023)

Contrast-Enhanced Spectral Mammography in the Evaluation of Breast Microcalcifications: Controversies and Diagnostic Management
por: Nicosia, Luca, et al.
Publicado: (2023)

Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor
por: Williamson, Laura M., et al.
Publicado: (2019)

Grade 3 well-differentiated neuroendocrine tumor of the rectum: a case report
por: Ito, Misato, et al.
Publicado: (2020)

Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms
por: Lacombe, Caroline, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fm49j51r0c3nhl6m6biu06ee9c